Abstract Details

Title Fingolimod (Gilenya®) in Combination with an SSRI or SNRI Antidepressant in Multiple Sclerosis Patients with Mild to Moderate Depression: Design of a Phase IIIb Study (REGAIN)

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 135

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Katrin Schuh (Novartis Pharma)	Katrin Schuh has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Matthias Meergans	No disclosure on file
Antonios Bayas	No disclosure on file
Kenneth J. Shulman, DO (Teva Pharmaceuticals)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��